| Balaganesh Gopurala, MD | |
|
11480 Brookshire Ave Ste 309, Downey, CA 90241-5025 | |
| (562) 869-1201 | |
| (562) 869-1281 |
| Full Name | Balaganesh Gopurala |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 31 Years |
| Location | 11480 Brookshire Ave Ste 309, Downey, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316967854 | NPI | - | NPPES |
| 009936594 | Medicaid | AL | |
| 009936597 | Medicaid | AL | |
| 51534632 | Other | AL | BLUE CROSS BLUE SHIELD |
| 009936596 | Medicaid | AL | |
| 51534631 | Other | AL | BLUE CROSS BLUE SHIELD |
| H78600 | Other | AL | HEALTHSPRING OF ALABAMA |
| 51003582 | Other | AL | BLUE CROSS BLUE SHIELD |
| H78600 | Other | AL | UNITED HEALTHCARE |
| P00314189 | Other | AL | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 00024965 (Alabama) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | C139871 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Oncology Institute Ca, A Professional Corporation | 5698872398 | 69 |
News Archive
UCB Canada Inc. is proud to announce the launch of the 2010 UCBeyond Scholarship Program. During its four-year lifespan, the UCBeyond Scholarship has allocated almost 70 educational bursaries worth close to $350,000.00 CAN to students living with chronic illnesses such as rheumatoid arthritis, Crohn's disease and epilepsy.
Among the hundred million or so cases of coronavirus disease 2019 (COVID-19) that have occurred since the pandemic began, pregnant women have been a conspicuous risk group. However, the exact nature of the risk they and their fetuses face, and the mechanism by which it operates, is far from clear.
Building on decades of research into how the body's electrical field affects skin regeneration, scientists at Johnson & Johnson Consumer Companies, Inc., have discovered how to harness the power of bioelectricity to help improve skin rejuvenation. The new innovation, called CYTOMIMIC™ Technology, is a proprietary, patented technology that combines essential minerals to deliver biological levels of electric signals similar to the skin's natural bioelectricity.
Genervon scientists have confirmed that the target of GM604 regulates over 4,000 genes. More significantly, it modifies ALS disease progression by modulating at least 30 significant ALS related genes. It does this through at least 8 pathways, potentially more, and up to 22 biological processes.
› Verified 6 days ago
| Entity Name | The Oncology Institute Ca, A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275651515 PECOS PAC ID: 5698872398 Enrollment ID: O20070514000607 |
News Archive
UCB Canada Inc. is proud to announce the launch of the 2010 UCBeyond Scholarship Program. During its four-year lifespan, the UCBeyond Scholarship has allocated almost 70 educational bursaries worth close to $350,000.00 CAN to students living with chronic illnesses such as rheumatoid arthritis, Crohn's disease and epilepsy.
Among the hundred million or so cases of coronavirus disease 2019 (COVID-19) that have occurred since the pandemic began, pregnant women have been a conspicuous risk group. However, the exact nature of the risk they and their fetuses face, and the mechanism by which it operates, is far from clear.
Building on decades of research into how the body's electrical field affects skin regeneration, scientists at Johnson & Johnson Consumer Companies, Inc., have discovered how to harness the power of bioelectricity to help improve skin rejuvenation. The new innovation, called CYTOMIMIC™ Technology, is a proprietary, patented technology that combines essential minerals to deliver biological levels of electric signals similar to the skin's natural bioelectricity.
Genervon scientists have confirmed that the target of GM604 regulates over 4,000 genes. More significantly, it modifies ALS disease progression by modulating at least 30 significant ALS related genes. It does this through at least 8 pathways, potentially more, and up to 22 biological processes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Balaganesh Gopurala, MD 11480 Brookshire Ave Ste 309, Downey, CA 90241-5025 Ph: (562) 869-1201 | Balaganesh Gopurala, MD 11480 Brookshire Ave Ste 309, Downey, CA 90241-5025 Ph: (562) 869-1201 |
News Archive
UCB Canada Inc. is proud to announce the launch of the 2010 UCBeyond Scholarship Program. During its four-year lifespan, the UCBeyond Scholarship has allocated almost 70 educational bursaries worth close to $350,000.00 CAN to students living with chronic illnesses such as rheumatoid arthritis, Crohn's disease and epilepsy.
Among the hundred million or so cases of coronavirus disease 2019 (COVID-19) that have occurred since the pandemic began, pregnant women have been a conspicuous risk group. However, the exact nature of the risk they and their fetuses face, and the mechanism by which it operates, is far from clear.
Building on decades of research into how the body's electrical field affects skin regeneration, scientists at Johnson & Johnson Consumer Companies, Inc., have discovered how to harness the power of bioelectricity to help improve skin rejuvenation. The new innovation, called CYTOMIMIC™ Technology, is a proprietary, patented technology that combines essential minerals to deliver biological levels of electric signals similar to the skin's natural bioelectricity.
Genervon scientists have confirmed that the target of GM604 regulates over 4,000 genes. More significantly, it modifies ALS disease progression by modulating at least 30 significant ALS related genes. It does this through at least 8 pathways, potentially more, and up to 22 biological processes.
› Verified 6 days ago
Brandon Lui, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 9333 Imperial Hwy, Downey, CA 90242 Phone: 562-657-9000 | |
Mr. Nazar Al-bussam, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 11411 Brookshire Ave, Ste 503, Downey, CA 90241 Phone: 562-861-8853 Fax: 562-861-8820 | |
Betzabe M Alday, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 7601 Imperial Hwy, Downey, CA 90242 Phone: 562-803-0124 Fax: 562-803-5569 | |
Dr. Kiran Pandey, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9333 Imperial Hwy, Downey, Downey, CA 90242 Phone: 877-608-0044 | |
Sohail Afra, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 9449 Imperial Hwy # C-228, Downey, CA 90242 Phone: 562-657-4958 | |
Ava Azimi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11500 Brookshire Ave, Downey, CA 90241 Phone: 562-904-5000 | |
Bhavik V Thakkar, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11525 Brookshire Ave, Suite 400, Downey, CA 90241 Phone: 562-869-4497 Fax: 562-869-6317 |